30 Oct 2026, 11:22
Presentations—
Announcement history available from 1 August 2025
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 30 Oct 2026, 11:22 | Notice of Annual General Meeting/Proxy Form | Presentations | — | 08001, 08004, 14014, 16002 | |
| 30 Oct 2026, 09:16 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19001, 19006 | |
| 28 Oct 2026, 10:56 | Proposed issue of securities - BGT | Securities Administration | — | 06013 | |
| 19 Oct 2026, 09:59 | Bio-Gene Receives $343,000 R&D Tax Incentive | Periodic Reports | — | 03014 | |
| 12 Oct 2026, 09:20 | Date of 2026 Annual General Meeting | Meetings & Governance | — | 08006 | |
| 7 Oct 2026, 10:21 | Flavocide efficacy results against deer ticks published | Company Update | — | 11001 | |
| 28 Aug 2026, 12:20 | Corporate Governance Statement | Company Administration | — | 03024 | |
| 28 Aug 2026, 12:20 | Appendix 4G | Company Administration | — | 03025 | |
| 28 Aug 2026, 12:13 | Appendix 4E and 2026 Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 27 Aug 2026, 12:43 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 27 Aug 2026, 12:38 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 10 Aug 2026, 13:49 | Notification regarding unquoted securities - BGT | Securities Administration | — | 06021 | |
| 10 Aug 2026, 13:33 | Change of Director's Interest Notice x 4 | Director Interests | — | 02009 | |
| 10 Aug 2026, 13:30 | Placement Completed and Cleansing Notice | Capital Raising | — | 06003, 06017, 06018 | |
| 10 Aug 2026, 13:02 | Application for quotation of securities - BGT | Securities Administration | — | 06020 | |
| 10 Aug 2026, 12:57 | Application for quotation of securities - BGT | Securities Administration | — | 06020 | |
| 10 Aug 2026, 12:56 | Application for quotation of securities - BGT | Securities Administration | — | 06020 | |
| 5 Aug 2026, 13:03 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 31 July 2026, 11:25 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 6 July 2026, 14:38 | Notice of Extraordinary General Meeting/Proxy Form | Meetings & Governance | — | 08002, 08004, 16002 | |
| 24 June 2026, 08:23 | Result of Security Purchase Plan | Capital Raising | — | 06017 | |
| 24 June 2026, 08:22 | Application for quotation of securities - BGT | Securities Administration | — | 06020 | |
| 5 June 2026, 08:59 | Update - Proposed issue of securities - BGT | Securities Administration | — | 06013 | |
| 3 June 2026, 09:49 | Investor Update Webinar | Presentations | — | 14014 | |
| 2 June 2026, 15:18 | Launch of Security Purchase Plan | Capital Raising | — | 06017 | |
| 2 June 2026, 09:48 | Placement Update and Section 708A(5)(e) Notice | Capital Raising | — | 06003, 06018 | |
| 2 June 2026, 09:40 | Application for quotation of securities - BGT | Securities Administration | — | 06020 | |
| 2 June 2026, 09:33 | Proposed issue of securities - BGT | Securities Administration | — | 06013 | |
| 26 May 2026, 10:01 | Proposed issue of securities - BGT | Securities Administration | — | 06013 | |
| 26 May 2026, 10:01 | Proposed issue of securities - BGT | Securities Administration | — | 06013 | |
| 26 May 2026, 10:01 | Investor Presentation - Placement | Presentations | — | 03026 | |
| 26 May 2026, 09:59 | Results of Placement | Capital Raising | MS | 06003, 06017, 09014 | |
| 22 May 2026, 09:28 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 21 May 2026, 08:34 | BGT to expand Flavocide and Qcide evaluation to Asia | Company Update | — | 11001 | |
| 6 May 2026, 09:49 | Key insecticide combinations patent allowed in the US | Company Update | — | 11001 | |
| 27 Apr 2026, 11:55 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 20 Apr 2026, 09:32 | Investor Presentation | Presentations | — | 03026, 12008 | |
| 14 Apr 2026, 09:33 | Change of Auditor | Other | — | 12018 | |
| 26 Mar 2026, 12:20 | NWR Healthcare Conference Presentation | Presentations | — | 03026 | |
| 20 Mar 2026, 09:58 | Bio-Gene to present at NWR Healthcare Conference | Presentations | — | 14014 | |
| 16 Mar 2026, 08:18 | Sumitomo & Nakashima to launch Qcide products in Japan | Company Update | MS | 11001 | |
| 10 Mar 2026, 09:28 | Update on Qcide Production | Company Update | — | 11001 | |
| 3 Mar 2026, 09:05 | Regulatory Development of Flavocide | Company Update | MS | 11001 | |
| 24 Feb 2026, 09:35 | Appendix 4D and Half-Year Accounts 31 December 2025 | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 13 Feb 2026, 09:45 | Flavocide Acute Neurotoxicity Study Underway | Company Update | — | 11001 | |
| 9 Feb 2026, 09:31 | Flavocide Reproductive Toxicity Study Underway | Company Update | — | 11001 | |
| 2 Feb 2026, 09:11 | CFO and Company Secretary Appointment/Resignation | Company Administration | — | 12007, 12008 | |
| 30 Jan 2026, 08:24 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19002, 19007 | |
| 18 Dec 2025, 08:53 | U.S. Department of Defense Grant Programs Advance | Company Update | MS | 11001 | |
| 2 Dec 2025, 08:21 | Outcome of review of Continuous Disclosure Procedures | Company Update | — | 11001, 12008 |